Literature DB >> 10207344

Tuberculosis: 2. History of the disease in Canada.

S Grzybowski1, E A Allen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207344      PMCID: PMC1230197     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  THE EFFICIENCY OF POST-SANATORIUM MANAGEMENT OF TUBERCULOSIS. A STUDY OF ONE THOUSAND TUBERCULOUS PATIENTS DISCHARGED FROM SANATORIA IN ONTARIO.

Authors:  E A ALLEN; M STEWART; P JENEY
Journal:  Can J Public Health       Date:  1964-08

2.  Results of the treatment of tuberculosis before and since the introduction of chemotherapy.

Authors:  H E PUGSLEY; E A ALLEN; O T CHEUNG; H S COULTHARD; G L GALE
Journal:  Can Med Assoc J       Date:  1960-08-27       Impact factor: 8.262

Review 3.  The origin and erratic global spread of tuberculosis. How the past explains the present and is the key to the future.

Authors:  W W Stead
Journal:  Clin Chest Med       Date:  1997-03       Impact factor: 2.878

4.  Incidence of active tuberculosis in the native population of Canada.

Authors:  D A Enarson; S Grzybowski
Journal:  CMAJ       Date:  1986-05-15       Impact factor: 8.262

5.  Tuberculosis. A look at the world situation.

Authors:  S Grzybowski
Journal:  Chest       Date:  1983-12       Impact factor: 9.410

Review 6.  Epidemiology of tuberculosis and the role of BCG.

Authors:  S Grzybowski
Journal:  Clin Chest Med       Date:  1980-05       Impact factor: 2.878

7.  Tuberculosis in British Columbia among immigrants from five Asian countries, 1982-85.

Authors:  J S Wang; E A Allen; C W Chao; D Enarson; S Grzybowski
Journal:  Tubercle       Date:  1989-09

8.  Identification of a polymorphic nucleotide in oxyR specific for Mycobacterium bovis.

Authors:  S Sreevatsan; P Escalante; X Pan; D A Gillies; S Siddiqui; C N Khalaf; B N Kreiswirth; P Bifani; L G Adams; T Ficht; V S Perumaalla; M D Cave; J D van Embden; J M Musser
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

9.  An estimate of the future size of the tuberculosis problem in sub-Saharan Africa resulting from HIV infection.

Authors:  M Schulzer; J M Fitzgerald; D A Enarson; S Grzybowski
Journal:  Tuber Lung Dis       Date:  1992-02

10.  THE CHALLENGE OF TUBERCULOSIS IN DECLINE. A STUDY BASED ON THE EPIDEMIOLOGY OF TUBERCULOSIS IN ONTARIO, CANADA.

Authors:  S GRZYBOWSKI; E A ALLEN
Journal:  Am Rev Respir Dis       Date:  1964-11
View more
  6 in total

Review 1.  Tuberculosis: 13. Control of the disease among aboriginal people in Canada.

Authors:  J M FitzGerald; L Wang; R K Elwood
Journal:  CMAJ       Date:  2000-02-08       Impact factor: 8.262

2.  Fluoroscopy X-Ray Organ-Specific Dosimetry System (FLUXOR) for Estimation of Organ Doses and Their Uncertainties in the Canadian Fluoroscopy Cohort Study.

Authors:  A Iulian Apostoaei; Brian A Thomas; F Owen Hoffman; David C Kocher; Kathleen M Thiessen; David Borrego; Choonsik Lee; Steven L Simon; Lydia B Zablotska
Journal:  Radiat Res       Date:  2021-04-01       Impact factor: 2.841

Review 3.  Tuberculosis in Canada and the United States: a review of trends from 1953 to 2015.

Authors:  Samuel Kwaku Essien; Tasha Epp; Cheryl Waldner; Wendy Wobeser; Vernon Hoeppner
Journal:  Can J Public Health       Date:  2019-07-08

4.  Conventional and molecular epidemiology of tuberculosis in Manitoba.

Authors:  Kym S Blackwood; Assaad Al-Azem; Lawrence J Elliott; Earl S Hershfield; Amin M Kabani
Journal:  BMC Infect Dis       Date:  2003-08-13       Impact factor: 3.090

5.  Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspective.

Authors:  Philippe De Wals; Dick Menzies; Maziar Divangahi
Journal:  Can J Public Health       Date:  2020-11-19

6.  Estimation of Heights and Body Masses of Tuberculosis Patients in the Canadian Fluoroscopy Cohort Study for Use in Individual Dosimetry.

Authors:  Kathleen M Thiessen; A Iulian Apostoaei; Lydia B Zablotska
Journal:  Health Phys       Date:  2021-03-01       Impact factor: 2.922

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.